When was Akkure founded?

Akkure was founded in 2016 and raised its 1st funding round 5 years after it was founded.

Where is Akkure located?

Akkure is headquartered in Dublin, Ireland.

How many employees does Akkure have?

As of Aug 31, 2026, the latest employee count at Akkure is 1.

Is Akkure a funded company?

Akkure is a funded company, having raised a total of $3.37M across 3 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on 2021.

When was the latest funding round of Akkure?

Akkure's latest funding was a $***** Grant (prize money) round on Nov 22, 2022, with participation from 1 investor.

Where does Akkure rank among its competitors?

Akkure ranks 127th amongst 770 active competitors, of which 86 are funded. It stands 9th in terms of total funding among its competitors. The most recent competitor to raise funding was Cellanome, which secured $75.9M in Dec, 2025.

Who are the top competitors of Akkure?

Akkure's top competitors include Strand Life Sciences, BGI and Unlearn. Among them, Cellanome secured the most recent funding round in December, 2025.

Akkure - 2026 Company Profile, Team, Funding & Competitors

Company Details

Akkure is an online platform for genomics data analytics. The platform enables the user to control, manage data or provide rewards for sharing data. It also enables researchers to connect with organizations to order DNA test kits for genomics sequencing, receive results, and analyze genomics data. The company uses blockchain-based technology in order to share and manage research data analytics.

Key Metrics

Founded Year

2016

Location

Dublin, Ireland

Stage

Seed

Total Funding

$3.37M in 3 rounds

Latest Funding Round

Grant (prize money), Nov 22, 2022, $*****

Investors

Enterprise Ireland & 1 more

Ranked

127^th among 770 active competitors

Employee Count

1 as on Aug 31, 2026

Similar Companies

Strand Life Sciences & 923 more

View Akkure's full profile

Akkure has raised a total funding of $3.37M over 3 rounds. Its first funding round was on 2021. Its latest funding round was a Grant (prize money) round on Nov 22, 2022 for $*****. 1 investor participated in its latest round. Akkure has 2 institutional investors.

Here is the list of recent funding rounds of Akkure:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Nov 22, 2022	6083149	Grant (prize money)	8578386	5365131	2017296	3000282
Jan 29, 2021	3249610	Seed	7211285	8981131	5239456	5974790
2021	4217	Seed	9023	3285	Enterprise Ireland	6735

Access funding benchmarks and valuations. Sign up today!

View details of Akkure's funding rounds and investors

The founders of Akkure are Oran Rigby and Amy Hollingworth.

Here are the details of Akkure's key team members:

Oran Rigby: Co-Founder of Akkure.
Amy Hollingworth: Co-Founder of Akkure.

View details of Akkure's Founder profiles and Board Members

Akkure's employee count trend

Akkure has 1 employees as of Aug 26. Here is Akkure's employee count trend over the years:

Uncover Akkure's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Akkure include Strand Life Sciences, BGI and Unlearn. Here is the list of Top 10 competitors of Akkure, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Strand Life Sciences 2000, Bengaluru (India), Acquired	Provider of omics-based solutions for clinical genomics, systems biology, and drug discovery	$34.9M	Biomark Capital, WestBridge Capital & 92 others	74/100
2nd	BGI 1999, Shenzhen (China), Public	Provider of services in genome sequencing	-	Sequoia Capital China, Yunfeng Capital & 15 others	64/100
3rd	Unlearn 2017, San Francisco (United States), Series C	Developer of an AI platform for clinical trial design and analysis	$135M	EPIC Ventures, Altimeter Capital & 14 others	63/100
4th	Hexagon Bio 2017, Menlo Park (United States), Series B	Provider of bioinformatics tools for the analysis of microbial genomic sequencing data	$206M	The Column Group, Two Sigma Ventures & 10 others	62/100
5th	Cellanome 2020, Palo Alto (United States), Series B	Developer of the omic data platform for researchers	$119M	DFJ Growth, Premji Invest & 4 others	59/100
6th	Ryght 2023, Anaheim (United States), Series A	Generative AI platform focused on biopharma smart biomedical data	$7.25M	Foothill Ventures, Virtue & 4 others	54/100
7th	Enara Bio 2016, Oxford (United Kingdom), Series B	Developer of T-cell based cancer-cell interface for therapeutics	$84.1M	SV Health Investors, M Ventures & 36 others	53/100
8th	Virtonomy 2019, Munich (Germany), Series A	Provider of virtual patient simulation for medical device development	$9.69M	Dieter von Holtzbrinck Ventures, Companisto ... & 12 others	53/100
9th	Allelica 2017, Rome (Italy), Seed	Provider of genomic DNA tests for assessing predisposition to diseases & personalized nutrition	$1.81M	Valor Ventures, Pi Campus & 3 others	52/100
10th	Berry Genomics 2010, Beijing (China), Public	Provider of genetic testing products and tests	$16M	Legend Capital, TMCP & 6 others	50/100
127th	Akkure 2016, Dublin (Ireland), Seed	Provider of a blockchain technology based online platform for genomic data analytics	$3.37M	Enterprise Ireland, Digital Transformation Innovation Fund ... Read more	32/100